Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) requesting marketing approval of ...

Vanda Pharmaceuticals (VNDA) announced that a New Drug Application was submitted to the U.S. FDA requesting marketing approval of Bysanti for ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and pharma practices, blurring traditional industry lines. Key findings are powered by ...

Ascentage Pharma’s proprietary novel drugs, lisaftoclax & olverembatinib included in Chinese Society of Clinical Oncology 2025 Guidelines: Rockville, Maryland Wednesday, April 2 ...

China’s National Medical Products Administration (NMPA) has accepted Innocare Pharma Ltd.’s NDA for its second-generation pan-tropomyosin receptor kinase inhibitor, zurletrectinib (ICP-723), for ...

Ironwood must run a new Phase 3 trial after FDA talks, delaying its SBS drug approval despite strong results from prior ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has submitted its New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for TransCon CNP (navepegritide) for the ...

WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA ...